High-Flying Biotech Stock 360% Faces Trim, Top Holding
A biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
Explore which risk parity funds are retirement friendly and fit conservative to balanced retirement goals. A quick guide to evaluating suitability.
27,924 articlesA biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
A leading wealth manager just bought a notable position in a small-cap value ETF, highlighting renewed interest in ov...
Bitcoin slipped below $73,000 as ETF outflows intensified and risk-off trading took hold amid escalating geopolitical...
SpaceX captures headlines with bold tech and presumed multi-bagger upside. Still, the stock question isn’t simple. Th...
A major investment fund disclosed a $13.93 million exit from a booming AI investment in Q1 2026. Here’s what this mov...
Investors spar over which dividend ETF builds a steadier income stream. This analysis weighs SCHD's quality screen ag...
As leveraged ETFs surge in popularity, the active trader dominates turnover in these products, reshaping how markets ...
A veteran financial writer dives into a framework that aims to outpace the S&P over generations. Learn how Davis Fund...
Boone Capital just disclosed a fresh position in HealthEquity, raising questions about the stock's potential. This gu...
A mid-year 13F filing shows Sone Capital Management increasing its MarketAxess position. This article breaks down wha...
Crypto chatbots guide users through volatile markets, but a hidden threat called what prompt injection attack? can hi...
Geopolitical headlines, especially about Iran, push markets around in the short term. This guide helps long-term inve...